Company Logo Boost ROI by automating safety workflows, integrating multisource data, improving signal detection, and retaining human oversight for compliance. Dublin, Oct. 27, 2026 (GLOBE NEWSWIRE) -- "Artificial Intelligence (AI) in Pharmacovigilance Market Global Report 2026" has been added to ResearchAndMarkets.com's offering. The global artificial intelligence (AI) in pharmacovigilance market is experiencing rapid growth as pharmaceutical companies, healthcare organizations and regulators adopt advanced technologies to strengthen drug safety monitoring. The market is projected to increase from $0.77 billion in 2025 to $0.92 billion in 2026, representing a compound annual growth rate (CAGR) of 19.3%.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.